<DOC>
	<DOCNO>NCT00154167</DOCNO>
	<brief_summary>The purpose study : - determine NV-101 accelerates recovery numbness compare placebo - evaluate safety NV-101</brief_summary>
	<brief_title>Safety Efficacy Study NV-101 Dental Patients</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , multi-center study . One hundred twenty-two patient age 10-58 require treatment one four routine dental procedure enrol . The investigator license dentist private practice . Each patient receive one conventional injection either articaine epinephrine , lidocaine epinephrine , prilocaine epinephrine , mepivacaine levonordefrin . Local anesthetic inject 2 site . Injections local anesthetic place within 4mm constituted site . The injection ( ) study drug make near completion dental procedure require earlier 20 minute , later 70 minute , recent injection local anesthetic . Patients receive injection study drug ( 1.8 mL ) site local anesthetic inject ( i.e . 2 site ) . Patients self-evaluated return normal sensation lip , tongue , nose , chin palpation 5-minute interval begin 1 minute study drug injection continue minimum 3 hour achieve return normal sensation lip , tongue , nose , chin . Safety assess use Holter monitor , vital sign , pain rating , physical examination include oral cavity examination .</detailed_description>
	<mesh_term>Phentolamine</mesh_term>
	<criteria>Between 1065 year age Body weight 35 110 kg Healthy determine Investigator base medical history , physical examination , 12 Lead ECG Clinical laboratory test within reference range within clinically acceptable limit accord Investigator Normal lip , nose , chin , tongue sensation Women childbearing potential must agree use barrier contraception duration study ( Women childbearing potential included woman except premenstrual , whose menstrual period occur great equal one year menopause , surgically sterilize , hysterectomy ) Can understand sign inform consent document , communicate investigator , understand comply requirement protocol Clinically relevant history presence respiratory , gastrointestinal , renal , hepatic , hematological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , dermatological , connective tissue disease disorder Clinically relevant surgical history History alcoholism and/or drug abuse within past 5 year Significant infection know inflammatory process include viral infection Required prophylactic antibiotic SBE ( infectious endocarditis ) Had acute gastrointestinal symptom screen and/or baseline Allergies follow : lidocaine/epinephrine , articaine/epinephrine , prilocaine/epinephrine , bisulfites metasulfites , phentolamine Had use investigational drug and/or participate clinical trial within 30 day baseline Used pain reliever 24 hour prior anesthetic administration Required use nitrous oxide sedative perform schedule , eligible dental procedure Pregnancy , attempt conceive , lactate Used decongestant drug vasoactive moiety within 24 hour prior anesthetic administration</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>